Context Radiotherapy used for treating localized prostate cancer is effective at prolonging
cancer-specific and overall survival. Still, acute and late pelvic toxicities are a concern, with …

Background Evaluation of treatment options for localized prostate cancer (PCa) remains
among the highest priorities for comparative effectiveness research. Surgery and …

Importance Stereotactic body radiotherapy harnesses improvements in technology to allow
the completion of a course of external beam radiotherapy treatment for prostate cancer in the …

Purpose To jointly update the Cancer Care Ontario guideline on brachytherapy for patients
with prostate cancer to account for new evidence. Methods An Update Panel conducted a …

Importance Stereotactic body radiotherapy is a hypofractionated, cost-effective treatment
option for localized prostate cancer. Objective To characterize US national trends and the …

Purpose To compare the toxicities and cost of proton radiation and stereotactic body
radiotherapy (SBRT) with intensity-modulated radiotherapy (IMRT) for prostate cancer …

Primary treatment for many solid cancers includes surgical excision or radiation therapy,
with or without the use of adjuvant therapy. This can include the addition of radiation and …

Purpose Recent years have brought many changes in the management of localized prostate
cancer as national screening guidelines have been updated and diagnostic practice …

Importance Technical advances in treatment of prostate cancer and a better understanding
of prostate cancer biology have allowed for hypofractionated treatment courses using a …

Background To investigate whether the rate of stereotactic body radiation therapy-related
(SBRT-related) genitourinary (GU) toxicity is lower in patients with prostate cancer treated …